agilon health, inc.

Ticker: AGL

Class Period Start: 01/09/2023

Class Period End: 01/04/2024

Registration Deadline: 05/20/2024

A securities class action has been filed in the USDC W.D.TX. against agilon health, inc. (AGL) (“agilon” or the “Company”), on behalf (a) all persons and entities that purchased or otherwise acquired agilon health, inc. (“agilon” or the “Company”) common stock between January 9, 2023 through January 4, 2024, both dates inclusive (the “Class Period”); and (b) all persons and entities that purchased or otherwise acquired agilon common stock pursuant, or traceable, or both, to the secondary public offering (the “SPO”) Materials issued in connection agilon’s May 2023 SPO.

 

agilon, headquartered in Austin, Texas, generates profits from reducing medical expenditures. By partnering primarily with Medicare Advantage (“MA”) plans as well as traditional Medicare and commercial managed care organizations, agilon receives a fixed monthly payment from payers for each patient under its care. In return, agilon takes on the responsibility of managing the total cost and quality of care for those patients. This model incentivizes agilon and its contracted physician partners to focus on preventive care and improve health outcomes in order to control costs. If the total cost of caring for patients is less than the fixed payments agilon receives, it realizes a profit. However, if costs exceed the payments, agilon incurs a loss. This aspect of financial risk is inherent in agilon’s business model.

 

The Complaint alleges that, throughout the Class Period and in the SPO Materials, Defendants misled investors about agilon’s medical costs by:

(1) touting the Company’s purported visibility into utilization trends and medical costs;

(2) failing to disclose increased medical costs that agilon had incurred prior to and during the Class Period due to higher utilization of healthcare by MA patients;

(3) falsely stating that its accounting reserves for higher-than-expected medical costs were adequate;

(4) making false and misleading statements about the effectiveness of its business model;

(5) issuing overly optimistic financial guidance; and

(6) issuing risk disclosures that were materially false and misleading because they characterized adverse facts that had already materialized as mere possibilities.

After several Company reports, agilon’s stock closed at $8.63 on January 5, 2024.

 

If you purchased agilon common stock during the Class Period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.

 

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

If you suffered a loss on your investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Purchases

Sales

Please Note

Neither the submission to nor the receipt of information by Lowey Dannenberg or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* Indicates a required field.

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.